Cytogen, Inc. (KOSDAQ:217330)
South Korea
· Delayed Price · Currency is KRW 3,980.00
+320.00 (8.74%)
Last updated: Jun 10, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Bio | 2.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bio Growth | 519.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| System | 426.35M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| System Growth | 52.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 35.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -13.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Cell Cancer-based Liquid Biopsy Applications and Related Hardware Manufacturing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Cell Cancer-based Liquid Biopsy Applications and Related Hardware Manufacturing Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| United States | 2.32B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 833.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 48.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 32.69M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|